Polyethylene glycol-based protein nanocapsules for functional delivery of a differentiation transcription factor.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biomaterials

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.biomaterials.2012.04.012PMID 22521490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomaterials

  2020cited by this paper
• Redox-responsive nanocapsules for intracellular protein delivery.

  2011cited by this paper
• PEGylated inorganic nanoparticles.

  2011cited by this paper
• Endoprotease-mediated intracellular protein delivery using nanocapsules.

  2011cited by this paper
• PEGylated Inorganic Nanoparticles

  2011cited by this paper
• Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration

  2011cited by this paper
• Tailoring nanocarriers for intracellular protein delivery.

  2011cited by this paper
• Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives.

  2010cited by this paper
• Probing protease activity by single-fluorescent-protein nanocapsules.

  2010cited by this paper
• Direct conversion of fibroblasts to functional neurons by defined factors

  2010cited by this paper
• 17-P022 Virus-free induction of pluripotency and subsequentexcision of reprogramming factors

  2009cited by this paper
• Supplemental Data Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

  2009cited by this paper
• Protein nanocapsule weaved with enzymatically degradable polymeric network.

  2009cited by this paper
• A census of human transcription factors: function, expression and evolution

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• A fresh look at iPS cells.

  2009cited by this paper
• Transduction of MyoD protein into myoblasts induces myogenic differentiation without addition of protein transduction domain.

  2009cited by this paper
• Insights from genomic profiling of transcription factors

  2009cited by this paper
• Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

  2009cited by this paper
• piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

  2009cited by this paper
• c-Jun is a negative regulator of myelination

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Generation and Regeneration of Cells of the Liver and Pancreas

  2008cited by this paper
• The effect of particle design on cellular internalization pathways

  2008cited by this paper
• Regenerative medicine: Short cut to cell replacement

  2008cited by this paper
• Cooperative Synergy between NFAT and MyoD Regulates Myogenin Expression and Myogenesis*

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• MyoD uses overlapping but distinct elements to bind E-box and tetraplex structures of regulatory sequences of muscle-specific genes

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies

  2007cited by this paper
• Effect of Cell-Based Intercellular Delivery of Transcription Factor GATA4 on Ischemic Cardiomyopathy

  2007cited by this paper
• In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Influence of protein transduction domains on intracellular delivery of macromolecules

  2006cited by this paper
• The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription

  2005cited by this paper
• Intrinsically unstructured proteins and their functions

  2005cited by this paper
• E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle‐specific gene transcription

  2005cited by this paper
• Homodimeric MyoD Preferentially Binds Tetraplex Structures of Regulatory Sequences of Muscle-specific Genes*

  2005cited by this paper
• MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions

  2005cited by this paper
• Stepwise reprogramming of B cells into macrophages.

  2004cited by this paper
• Cellular and molecular regulation of muscle regeneration.

  2004cited by this paper
• Functional, Persistent, and Extended Liver to Pancreas Transdifferentiation*

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Furin at the cutting edge: From protein traffic to embryogenesis and disease

  2002cited by this paper
• Supporting Online Material

  2002cited by this paper
• Related Expression of MyoD and Myf5 with Myosin Heavy Chain Isoform Types in Bovine Adult Skeletal Muscles

  2002cited by this paper
• bHLH transcription factor MyoD affects myosin heavy chain expression pattern in a muscle-specific fashion.

  2001cited by this paper
• c-Jun mediates axotomy-induced dopamine neuron death in vivo

  2001cited by this paper
• The basic helix-loop-helix protein family: comparative genomics and phylogenetic analysis.

  2001cited by this paper
• Defining the drug incorporation properties of PLA-PEG nanoparticles.

  2000cited by this paper
• Transcription factors: an overview.

  1997cited by this paper
• The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist

  1997cited by this paper
• Transcription-factor mutations and disease.

  1996cited by this paper
• Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro.

  1994cited by this paper
• Folding topology of the disulfide-bonded dimeric DNA-binding domain of the myogenic determination factor MyoD.

  1992cited by this paper
• Molecular characterization of helix-loop-helix peptides.

  1992cited by this paper
• Transcription factors and mammalian development.

  1992cited by this paper
• The myoD gene family: nodal point during specification of the muscle cell lineage.

  1991cited by this paper
• Regulation of gene expression in vivo by liposome-mediated delivery of a purified transcription factor.

  1990cited by this paper
• MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer.

  1989cited by this paper
• Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle

  1977cited by this paper
• Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization.

  1976cited by this paper
• Proteinase K from Tritirachium album Limber.

  1974cited by this paper

• Cell and tissue reprogramming: Unlocking a new era in medical drug discovery

  2025cites this paper
• Polymer-mediated Protein/Peptide Therapeutic Stabilization: Current Progress and Future Directions

  2024cites this paper
• Advances and applications of biomimetic biomaterials for endogenous skin regeneration

  2024cites this paper
• Engineered biomaterials in stem cell-based regenerative medicine

  2023cites this paper
• Nonlinear control designs and their application to cancer differentiation therapy.

  2023cites this paper
• Bioactive materials for in vivo sweat gland regeneration

  2023cites this paper
• Biomaterials for Recruiting and Activating Endogenous Stem Cells in situ Tissue Regeneration.

  2022cites this paper
• In Situ Encapsulation of Biologically Active Ingredients into Polymer Particles by Polymerization in Dispersed Media

  2022cites this paper
• Protein nanocapsules as a smart drug delivery platform

  2022cites this paper
• Protein nanocapsules based vectors for efficient gene transfection

  2021cites this paper
• Nanotechnologies for Intracellular Protein Delivery: Recent Progress in Inorganic and Organic Nanocarriers

  2021cites this paper
• Cargo‐Templated Crosslinked Polymer Nanocapsules and Their Biomedical Applications

  2021cites this paper
• The Application of Nanomaterial in Skeletal Muscle Regeneration

  2021cites this paper
• Engineered biomaterials for in situ tissue regeneration

  2020cites this paper
• Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming.

  2020cites this paper
• In situ polymerization on biomacromolecules for nanomedicines

  2018cites this paper
• Transduction Methods for Cytosolic Delivery of Proteins and Bioconjugates into Living Cells

  2018cites this paper
• Transcription factors: Time to deliver.

  2018cites this paper
• Magnetically Guided Protein Transduction by Hybrid Nanogel Chaperones with Iron Oxide Nanoparticles.

  2016cites this paper
• Degradation behavior and biosafety studies of the mPEG-PLGA-PLL copolymer.

  2016cites this paper
• Nanomaterials for Engineering Stem Cell Responses

  2015cites this paper
• A Peptide‐Network Weaved Nanoplatform with Tumor Microenvironment Responsiveness and Deep Tissue Penetration Capability for Cancer Therapy

  2015cites this paper
• In vivo delivery of transcription factors with multifunctional oligonucleotides

  2015cites this paper
• Promoting Wound Healing by Engineering Enzyme-Responsive Delivery of Multiple Proteins and Amphiphilic Injectable Hydrogel - eScholarship

  2015cites this paper
• Activation Approaches on Delivery of Imaging and Therapeutic Agents

  2014cites this paper